Contemporary assessment of short- and functional 90-days outcome in old intensive care patients suffering from COVID-19

J Crit Care. 2025 Apr:86:154984. doi: 10.1016/j.jcrc.2024.154984. Epub 2024 Dec 3.

Abstract

Purpose: There are limited data about the outcome of old intensive care (ICU) patients suffering from Covid-19 in the post-vaccination era. This study distinguishes the pre- and post-acute illness living conditions of ICU survivors from non-survivors.

Methods: This prospective international multicenter study included 642 old (≥ 70 years) ICU patients, including data ranging from pre-illness condition to functional 90-days follow-up. The primary endpoint was the difference of living conditions of ICU-survivors before ICU admission and 90-days after ICU discharge. Secondary outcomes were 90-days mortality, and quality of life.

Results: A total of 642 patients were included. Significantly more ICU survivors lived at their own homes without support before ICU admission than non-survivors (p = 0.016), while more non-survivors resided in nursing homes (p = 0.016). ICU mortality was 39 %, 30-days and 90 days mortality were 47 %and 55 %. After 90 days, only 22 % maintained the same living conditions. Surviving patients viewed ICU admission positively after 90 days, while relatives were more uncertain. Quality of life indicated a self-reported average score of 60 (50-75).

Conclusion: Living conditions influence the outcome of critically ill old patients suffering from Covid-19. Only a minority returned to their initial habitat after ICU survival. Trial registration numberNCT04321265.

Keywords: COVIP-study; Covid-19; Elderly; Long-term outcomes.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • COVID-19* / mortality
  • COVID-19* / therapy
  • Critical Care*
  • Female
  • Humans
  • Intensive Care Units* / statistics & numerical data
  • Male
  • Nursing Homes / statistics & numerical data
  • Prospective Studies
  • Quality of Life*
  • SARS-CoV-2
  • Survivors / statistics & numerical data

Associated data

  • ClinicalTrials.gov/NCT04321265